TECHNOLOGY

TECHNOLOGY

MeMed has created a platform for discovery, development and validation of novel diagnostic solutions aimed at improving the management of patients with infectious diseases and inflammatory disorders. The platform relies on a unique combination of molecular and cellular immunology, bioinformatics, big data analysis and clinical knowledge.

The paradigm shift underlying MeMed’s technology is to use the human immune system as the disease sensor, instead of seeking to identify or isolate the invading pathogen. Crafted by nature, the human immune system has evolved for hundreds of millions of years to respond differentially to viruses and bacteria and activate distinctive physiological pathways. Our platform screens through potential targets and identifies key players in these pathways that circulate in the blood and can serve as characteristic ‘immunological fingerprints’ for bacterial, viral or non-infectious diseases.

 
 
MeMed’s platform has been used to develop and validate several products including ImmunoXpert™, a CE marked diagnostic tool for distinguishing between bacterial and viral infections at the hospital and emergency department setting, and ImmunoPoC™, a hand-held device currently in development for detecting the source of infection at the point-of-care. MeMed’s approach achieves accurate diagnosis with rapid time to results. Additionally, the approach has two unique advantages: (i) it can diagnose cases where the infection site is not readily accessible or is unknown, and (ii) it is insensitive to the presence of colonizers, which is one of the biggest challenges of current infectious disease diagnostics.